Luca Roncati | Pharmacovigilance | Best Academic Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Luca Roncati | Pharmacovigilance | Best Academic Researcher Award

Link Campus University | Italy

Prof. Dr. Luca Roncati is a distinguished Italian pathologist, physician-scientist, and academic leader whose extensive contributions have significantly advanced modern medical science. With a strong focus on senology, gynecologic oncology, gynecopathology, and hematopathology, he stands as a prominent figure in the global medical community. Dr. Roncati has an impressive record of 228 scientific publications, collectively cited in over 1,073 documents with more than 1,738 total citations, reflecting the profound influence and credibility of his research across various medical disciplines.Renowned for his groundbreaking discoveries, Dr. Roncati is the eponym of the Roncati–Manenti Triad, a key diagnostic concept in gynecologic oncology, and the describer of T rex lymphoma, a rare hematological condition that broadened the understanding of lymphoid malignancies. As a pioneering researcher in COVID-19, his investigations provided critical insights into viral pathogenesis and immune mechanisms, shaping the scientific response during the global pandemic. Furthermore, his innovative work in nanopathology has paved the way for the integration of nanotechnology into modern diagnostic pathology, offering revolutionary approaches to disease detection at the molecular level.Beyond research, Dr. Roncati is a full-time Professor of Pathology at Link Campus University in Rome, where he mentors future medical professionals and drives forward-thinking educational programs in biomedical sciences. Simultaneously, he leads as the Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where his expertise in women’s health, oncology, and diagnostic pathology enhances patient care and clinical outcomes.An award-winning author, academic editor, and inventor of anti-cancer patents, Dr. Roncati’s contributions exemplify the synergy between innovation, clinical excellence, and scientific discovery. His scholarly achievements, coupled with his dedication to advancing medical knowledge, have established him as one of the most influential figures in contemporary pathology and translational medicine. Through his research, publications, and leadership, Prof. Dr. Luca Roncati continues to inspire a new generation of scientists and clinicians in their pursuit of excellence and innovation in healthcare.

Profile: Scopus

Featured Publications

Roncati, L., et al. (2025). Erratum: Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of Clinical Microbiology and Antimicrobials.

Roncati, L., et al. (2025). Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of Clinical Microbiology and Antimicrobials.

Roncati, L., et al. (2025). pDNA impurities in mRNA vaccines. Editorial, Open Access.

Roncati, L., et al. (2025). Thoracic aortic pseudoaneurysm: Inside its pathophysiology. Vascular.

Roncati, L., et al. (2025). Adjuvant metronomic chemotherapy after surgery in pT1–T2 N0 M0 HER2-positive and ER/PR-positive breast cancer plus targeted therapy, anti-hormonal therapy, and radiotherapy, with or without immunotherapy: A new operational proposal. Editorial, Open Access.

Roncati, L., et al. (2025). Ozone–oxygen therapy to prevent HPV-related cancers of the lower gynecological tract in infected patients: The rationale for further developments. Cancers. [Open Access]

Roncati, L., et al. (2025). COVID-19 and upper limb compression neuropathies: A review. Review Article, Open Access.

Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

Ohidul Alam | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Ohidul Alam | Drug Safety and Risk Management | Best Researcher Award

Dr. Ohidul Alam, Jiangsu University, China

Dr. Ohidul Alam is an Environmental Engineer specializing in heavy metals, microplastics, and waste management. He earned his Ph.D. from East China University of Science and Technology (2021) and currently works as a Postdoctoral Fellow at Jiangsu University, China. 🔬 His research focuses on eco-friendly wastewater treatment, hazardous waste recycling, and environmental pollution assessment. With expertise in advanced analytical techniques (ICP-MS, XRF) and life cycle assessment, he has published extensively in top environmental journals. 🧪 Passionate about sustainable development and climate change, Dr. Alam actively contributes to environmental awareness through academic writing and collaborative projects worldwide.

Publication Profile

Google Scholar

Education

Dr. Ohidul Alam has a rich academic background in environmental sciences and engineering 🌱. He earned his Ph.D. in Environmental Engineering from the East China University of Science and Technology, Shanghai 🇨🇳 (2016–2021), preceded by an M.Eng. from the UNEP-Tongji Institute for Sustainable Development, Tongji University (2014–2016) 🧪. Earlier, he completed his M.S. and B.Sc. (Hons.) in Environmental Science from the University of Chittagong, Bangladesh 🇧🇩. His foundational education includes HSC from Government City College and SSC from Shilkhali High School in Cox’s Bazar. 🏫 This strong educational journey laid the groundwork for his impactful environmental research 🌏.

Experience

🧑‍🔬 Dr. Ohidul Alam has built an impressive career in environmental research and sustainability 🌿. Currently, he serves as a Post-doctoral Research Fellow at Jiangsu University, China 🇨🇳. His prior roles include Environmental Officer at SEP-IDF and Consultant at DM WATCH and SETS 🏢. His expertise spans hazardous waste, microplastics, climate change, and wastewater treatment 💧. With experience in academic research, project implementation, statistical analysis, and lab techniques like ICP-MS and XRD 🔬, he also writes on environmental topics for leading dailies 📰. Dr. Alam is fluent in Bangla and English and skilled in SPSS and OriginPro 💻.

Awards

Dr. Ohidul Alam has earned several prestigious awards and scholarships for his outstanding academic and research achievements 🌟. He received the Chinese Scholarship Council (CSC) and Marine Scholarship of China (MSC) in 2014 🇨🇳. In 2015, he was honored with Tongji University President Scholarship (2nd prize) 🥈, followed by the Shanghai Municipal Government Scholarship in 2016 🎓. His paper won first prize at the International Student Conference on Environment and Sustainability in 2017 📄🌍. In 2018, he received the ECUST Comprehensive Scholarship (1st prize) for academic excellence and remarkable research contributions .

Research Focus

Dr. Ohidul Alam’s research primarily focuses on environmental science, with a strong emphasis on waste management, environmental pollution, and sustainability. His work explores diverse aspects such as municipal solid waste management, plastic pollution, heavy metals contamination, and eco-friendly remediation technologies. He contributes significantly to understanding the environmental impacts of plastic bags, healthcare waste management, and green business opportunities in Bangladesh. Additionally, Dr. Alam’s recent interests include adsorption techniques for water purification and life cycle assessments. His interdisciplinary research combines chemistry, engineering, and public health to foster a more sustainable and cleaner environment.

Publication Top Notes

An in-depth review on municipal solid waste management, treatment and disposal in Bangladesh

Characteristics of plastic bags and their potential environmental hazards

Determination of the selected heavy metal and metalloid contents in various types of plastic bags

Heavy metals dispersion during thermal treatment of plastic bags and its recovery

Remediation of heavy metals polluted soil environment: A critical review on biological approaches

A preliminary life cycle assessment on healthcare waste management in Chittagong City, Bangladesh

Application of environmental ethics for sustainable development and conservation of Saint Martin s Island in Bangladesh

A deeper look into the inner factors associated to healthcare waste management in Chittagong–the commercial capital of Bangladesh

An investigation into the green business opportunity for the new entrepreneurs in the municipal wastes recycling sector of Bangladesh

Heavy metals detection and removal from contaminated water: A critical review of adsorption methodsA critical review on advances in remediation of toxic heavy metals contaminated solids by chemical processes

Ms. Tahere Abdollahi |Drug Safety and Risk Management |Women Researcher Award

Published on by Top Pharmaceutical

Ms. Tahere Abdollahi|Drug Safety and Risk Management |Women Researcher Award

Ms. Tahere Abdollahi at Hamadan University of Medical Sciences,Iran

PROFILE  

Orcid

Early Academic Pursuits 🎓

Tahere Abdollahi embarked on her academic journey with a strong foundation in Occupational Health Engineering. She pursued a Master’s degree in this field at Hamadan University of Medical Sciences, which is renowned for producing professionals with expertise in healthcare and occupational safety. Her academic focus on occupational health was driven by a passion for improving workplace environments, particularly in industries dealing with hazardous substances. During her early years as a student, Tahere developed a keen interest in the impact of industrial chemicals and drugs on human health, a theme that would shape her future research.

Her commitment to academic excellence allowed her to gain a comprehensive understanding of the science of occupational health. She was actively involved in laboratory work, field studies, and academic discussions, all of which solidified her knowledge base in the subject. These early academic experiences laid the groundwork for her future endeavors as an occupational health consultant and researcher.

Professional Endeavors 👩‍⚕️

Currently, Tahere Abdollahi holds a significant role as an Occupational Health Consultant in the medical equipment industry. Her expertise allows her to offer critical insights into the health risks associated with medical environments and equipment, ensuring that workers in this sector remain protected from occupational hazards. Her consulting work extends to evaluating the safety of equipment used in healthcare settings, as well as suggesting improvements to reduce potential risks.

In addition to her consulting role, Tahere continues to engage in academic and research activities. Her involvement in ongoing research projects reflects her commitment to advancing the field of occupational health. By focusing on industries with high exposure risks, such as ferrosilicon production and oncology nursing, she highlights the often-overlooked dangers in these environments, contributing to the improvement of workplace health standards.

Contributions and Research Focus 🔬

One of Tahere’s notable research contributions includes a study titled “Evaluating oxidative stress biomarkers in oncology nurses exposed to antineoplastic drugs: A cross-sectional study”, which is indexed in Scopus. This research delved into the oxidative stress faced by nurses who are regularly exposed to antineoplastic drugs, which are commonly used in cancer treatments. The study provided valuable data on the biomarkers associated with oxidative stress in these healthcare workers, emphasizing the need for better protective measures and health monitoring in hospitals and oncology departments.

Her current research focuses on the ferrosilicon industry, where she is studying the impact of chemical exposure on workers’ health. The goal of this study is to identify key biomarkers of oxidative stress and other health concerns that can arise from prolonged exposure to industrial chemicals, with a view to proposing solutions that can mitigate these risks. Through these projects, Tahere has made a significant contribution to both the occupational health and healthcare fields by addressing the unseen risks faced by workers.

Accolades and Recognition 🏆

While still early in her career, Tahere Abdollahi has already gained recognition for her research work, particularly her study on oxidative stress in oncology nurses. This research has been published in a Scopus-indexed journal, an achievement that speaks to the quality and relevance of her work. Her contribution to occupational health through her research is commendable, and her work has the potential to influence safety regulations and practices in healthcare settings.

Tahere has also applied for the Best Researcher Award in the international top pharmaceutical awards, which would serve as a well-deserved recognition for her ongoing dedication and impactful work in the field of occupational health.

Impact and Influence 🌍

The research and professional contributions of Tahere Abdollahi extend beyond academia. Her work on evaluating oxidative stress biomarkers among healthcare professionals has highlighted the potential long-term health risks faced by oncology nurses and other healthcare workers. This has led to a broader discussion in medical circles about improving safety protocols and protective measures for workers exposed to hazardous substances in hospitals and medical settings.

Her influence is also being felt in the industrial sector, where her ongoing research on ferrosilicon industries could lead to substantial improvements in workplace safety standards. By focusing on the health risks associated with chemical exposure, she is helping to drive the development of better monitoring systems and protective measures for workers in high-risk industries.

Legacy and Future Contributions 🌟

As an emerging researcher and consultant, Tahere Abdollahi’s future contributions are poised to have a lasting impact on occupational health, particularly in high-risk industries such as healthcare and chemical manufacturing. Her studies on oxidative stress and chemical exposure have the potential to influence policy changes and lead to more stringent safety regulations, benefiting workers across a wide range of sectors.

Her ongoing research promises to add further depth to her already impressive body of work, with a focus on enhancing worker safety and health in environments where exposure to hazardous substances is common. Tahere is likely to continue collaborating with experts across industries, contributing her knowledge and expertise to safeguard the health of countless workers.

In the years to come, her legacy will likely include being a key advocate for worker safety in occupational health. Her work will not only serve as a blueprint for future researchers but will also drive real-world changes in occupational safety standards.

Conclusion ✨

Tahere Abdollahi is a rising star in the field of occupational health engineering. Her academic and professional background, coupled with her impactful research on healthcare workers and industrial safety, positions her as an influential figure in her field. Through her work, she continues to champion the health and safety of workers, and her ongoing contributions are sure to leave a lasting mark on occupational health practices and policies worldwide.

🎓Publication 

Evaluating oxidative stress biomarkers in oncology nurses exposed to antineoplastic drugs: A cross-sectional study

  • Authors   : Abdollahi, T.; Ranjbar, A.; Faradmal, J.; Mohraz, M.H.; Assari, M.J.
  • Journal    :Oncology Nursing
  • Year         :2024